About 1 result found for searched term "1365287-97-3" (0.137 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M24631 | Emibetuzumab | c-Met |
| LY2875358 | ||
| Emibetuzumab (LY2875358) is a humanized bivalent MET antibody (IgG4 type). Emibetuzumab shows high neutralization and internalization activities, resulting in inhibition of both HGF-dependent and HGF-independent MET pathway activation and tumor growth. Emibetuzumab can be used in study of cancer. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
